Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Agnosia 7Breast Neoplasms 5Pain 4Pain, Postoperative 3Cancer Pain 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Postoperative Cognitive Complications 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Laryngeal Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Chronic Pain 1

Interventions

Morphine 6Surveys and Questionnaires 5Ketamine 4Sodium Chloride 3Saline Solution 3Lidocaine 3Educational Status 3Dexmedetomidine 3Cognitive Behavioral Therapy 3Anesthetics, Local 3Pregabalin 2Mindfulness-Based Stress Reduction 2Hypnosis 2Fentanyl 2Bupivacaine 2Botulinum Toxins, Type A 2Acetaminophen 2ziconotide 1tianeptine 1siltuximab 1onabotulinum toxin A 1erenumab 1Yoga 1Waiting Lists 1Transcutaneous Electric Nerve Stimulation 1Tramadol 1Therapeutics 1Telemedicine 1Tea 1Tamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chronic Pain × Analgesics, Opioid × Clear all
NCT01541124 2018-02-08

Morphine as First Drug for Cancer Pain

Federal University of São Paulo

Phase NA Completed
60 enrolled

Cancer Pain, Agnosia, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡